Additionally, cholesteatoma is characterized by bone erosion in the middle ear, and increased expression of receptor activator for nuclear factor-κB ligand (RANKL) and osteoprotegerin (OPG) is found in tissues of cholesteatoma [13,14,15]. Here, TNFSF11 is linked to cholesteatoma.